Articles

Effectiveness of a recombinant coagulation Factor IX–albumin fusion protein, rIX-FP, in haemophilia B patients: Results of a non-interventional study in Belgium

BJH - volume 12, issue 5, september 2021

C. Hermans MD, PhD, K. Peerlinck MD, PhD, A. Gadisseur MD, PhD, P. Quoc MD, V. Mondelaers MD, P. Maes MD, C. Van Geet MD, PhD

SUMMARY

The aim of this non-interventional, observational study conducted in haemophilia B patients in Belgium was to collect real-world data to confirm the efficacy and safety of rIX-FP established in pivotal clinical trials.

(BELG J HEMATOL 2021;12(5):203-6)

Read more

P03 PREVALENCE OF HETEROZYGOUS TYPE 2N VON WILLEBRAND DISEASE MUTATIONS IN A BELGIAN SURVEY

BJH - 2019, issue ?, february 2019

I. Vangenechten , J. Jongenotter , K. Jochmans MD, PhD, C. Orlando , A. Gothot MD, PhD, K. Vandenbosch , A. Gadisseur MD, PhD

Read more

P07 EVALUATION OF AN AUTOMATED VON WILLEBRAND FACTOR COLLAGEN BINDING ASSAY, HEMOSIL® ACUSTAR® VWF:CB

BJH - 2019, issue ?, february 2019

I. Vangenechten , M. Maes PhD, PharmD, A. Gadisseur MD, PhD

Read more

P35 PD-1 blockade in a patient with relapsed Hodgkin lymphoma post-allogeneic hematopoietic cell transplant: complete metabolic response without graft-versus-host-disease

BJH - 2018, issue Abstract Book BHS, february 2018

K. Saevels MD, A. Van De Velde MD, S. Anguille MD, PhD, A. Verlinden MD, A. Gadisseur MD, PhD, W. Schroyens MD, PhD, Z. Berneman MD, PhD

Read more
X